menjugate
Vaccineexperimental
Clinical trial activity
13 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
10
Phase 3
3
Phase 4
2
Earliest trial started Mar 1, 2003 (NCT00129116)
Timeline
Indications
Approved for
Studied for
- Bacterial Infections · Phase 3
- Diphtheria · Phase 2
- Diphtheria-Tetanus-acellular Pertussis Vaccines · Phase 2
- Diphtheria-Tetanus-Pertussis Vaccine · Phase 4
- Haemophilus influenzae · Phase 4
- Haemophilus influenzae type b · Phase 2
- Hepatitis B · Phase 4
- Immunization · Phase 1
- Meningitis, Meningococcal · Phase 3
- Meningococcal Infections · Phase 4
- Neisseria meningitidis · Phase 3
- Pertussis Vaccine · Phase 2
- Pneumococcal Infections · Phase 4
- Poliomyelitis · Phase 2
- Tetanus · Phase 2
- Tuberculosis · Phase 2
- Virus Diseases · Phase 3
Mechanism of action
- Neisseria meningitidisImmunity, active
Neisseria meningitidis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- menjugate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01896596 | Phase 4 | Jul 1, 2013 | Department of Health, United Kingdom, Public Health England, University of London |
| NCT01553279 | Phase 3 | Mar 1, 2012 | Sanofi-Aventis |
| NCT01171989 | Phase 2 | Aug 1, 2010 | GlaxoSmithKline |
| NCT01098474 | Phase 2 | Jul 1, 2010 | Aeras, GlaxoSmithKline |
| NCT01090453 | Phase 2 | May 1, 2010 | GlaxoSmithKline |
| NCT00871338 | Phase 2 | Jun 1, 2009 | GlaxoSmithKline |
| NCT00871741 | Phase 2 | Apr 1, 2009 | GlaxoSmithKline |
| NCT00674583 | Phase 3 | May 1, 2008 | GlaxoSmithKline |
| NCT00657709 | Phase 3 | Mar 1, 2008 | Novartis |
| NCT00625677 | Phase 4 | Feb 1, 2008 | National Institutes of Health (NIH), Public Health England |
| NCT06165276 | Phase 1 | Jul 25, 2006 | Sanofi-Aventis |
| NCT00262002 | Phase 2 | Sep 1, 2004 | Novartis |
| NCT00129116 | Phase 2 | Mar 1, 2003 | GlaxoSmithKline |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 7 | 7 | 2 | 2003 |
| Novartis | For profit | 2 | 2 | 2 | 2004 |
| Public Health England | Government | 2 | 2 | 1 | 2008 |
| Sanofi-Aventis | For profit | 2 | 2 | 2 | 2006 |
| Aeras | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Department of Health, United Kingdom | Government | 1 | 0 | 1 | 2013 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2008 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2013 |
8 organizations
Page 1 / 1